Skip to content
Research Article Open access CC BY 3.0

Enhancement of Bone Formation by Bone Morphogenetic Protein-2 Released from Poly (L-lactic-co-glycolic acid) Microsphere

Wen Zhao, Yuying Liu, Xudong Huang

Biotechnology Journal International · pp. 1223–1237 · Published 22 Oct 2014

10.9734/BBJ/2014/12949

Abstract

Enhancement of Bone Formation by Bone Morphogenetic Protein-2 Released from Poly (L-lactic-co-glycolic acid) Microsphere  An appropriate carrier acting as a sustained delivery vehicle for bone morphogenetic proteins (BMPs) is required for the maximal clinical effectiveness of these osteogenic proteins to enhance bone formation. The purpose of this study was to evaluate a low-molecular-weight poly(L-lactic-co-glycolic acid) (PLGA) copolymer as a synthetic, biodegradable carrier for the sustained delivery of bone morphogenetic protein-2 (BMP-2), and then to address the hypothesis that BMP-2 delivery from this vehicle could promote cell proliferation in vitro and ectopic bone formation in vivo. The BMP-2 was entrapped in microspheres of PLGA by using an improved water-in-oil-in water double-emulsion-solvent-extraction technique. The in vitro release kinetics of rhBMP-2 was determined by ELISA. Then we verified the effect of the sustained delivery vehicle on MSC cell proliferation. The ectopic bone induction in intramuscular implants of mice was evaluated at 2 and 4 weeks post-implantation. The results showed the PLGA microsphere released a total of 14.2%±0.71% rhBMP-2 at the initial phase followed by a prolonged release for 28 days. The rhBMP-2 released from the PLGA microsphere stimulated an increase in alkaline phosphatase (ALP) activity of MSC cells for 5 days in vitro, suggesting that the delivery vehicle releases BMP-2 for a prolonged period in an active form. Moreover, the released rhBMP-2 from the PLGA microsphere significantly promoted MSC cells proliferation after days 5 in culture. In vivo bone formation studies showed the rhBMP-2-loaded PLGA microsphere induced ectopic bone formation to a much greater extent than did rhBMP-2 treated mice. These results demonstrated that the PLGA copolymer material is capable of potentiating the osteogenic efficacy of BMP-2 and, as such, represents a promising delivery vehicle for BMP-2 for orthopedic and dental repair.

rhBMP-2 PLGA osteogenesis bone formation

References (56)

  1. 1 Tissue-engineered bone regeneration [DOI]
  2. 2 Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives [DOI]
  3. 3 Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering [DOI]
  4. 4 Skeletal Repair by in Situ Formation of the Mineral Phase of Bone [DOI]
  5. 5 Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion [DOI]
  6. 6 Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration [DOI]
  7. 7 Clinical and Radiographic Outcomes of Anterior Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2 [DOI]
  8. 8 Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects [DOI]
  9. 9 Geometry of Carriers Controlling Phenotypic Expression in BMP-Induced Osteogenesis and Chondrogenesis [DOI]
  10. 10 Overview of Bone Morphogenetic Proteins [DOI]
  11. 11 Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo [DOI]
  12. 12 Bone tissue engineering [DOI]
  13. 13 Potential applications and delivery strategies for bone morphogenetic proteins [DOI]
  14. 14 Heparin Potentiates the in Vivo Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2 [DOI]
  15. 15 Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering [DOI]
  16. 16 Bone regeneration using a microstereolithography-produced customized poly(propylene fumarate)/diethyl fumarate photopolymer 3D scaffold incorporating BMP-2 loaded PLGA microspheres [DOI]
  17. 17 Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds [DOI]
  18. 18 In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(l-lactide) [DOI]
  19. 19 Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold [DOI]
  20. 20 Growth factors in bone repair [DOI]
  21. 21 In vitro release of transforming growth factor-β1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels [DOI]
  22. 22 Transforming growth factor-β1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment [DOI]
  23. 23 Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2 [DOI]
  24. 24 Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery [DOI]
  25. 25 BMP-silk composite matrices heal critically sized femoral defects [DOI]
  26. 26 Controlled release of transforming growth factor ?1 from biodegradable polymer microparticles [DOI]
  27. 27 Chondrogenesis, osteogenesis and adipogenesis of canine mesenchymal stem cells: a biochemical, morphological and ultrastructural study [DOI]
  28. 28 In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin [DOI]
  29. 29 Co-culture of canine mesenchymal stem cells with primary bone-derived osteoblasts promotes osteogenic differentiation [DOI]
  30. 30 Enhanced Healing of Rat Calvarial Defects with MSCs Loaded on BMP-2 Releasing Chitosan/Alginate/Hydroxyapatite Scaffolds [DOI]
  31. 31 Preliminary report on the osteogenic potential of a biodegradable copolymer of polyactide (PLA) and polyglycolide (PGA) [DOI]
  32. 32 Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration [DOI]
  33. 33 Enhancement of Bone Growth by Sustained Delivery of Recombinant Human Bone Morphogenetic Protein-2 in a Polymeric Matrix [DOI]
  34. 34 Comparison of OP-1 Putty (rhBMP-7) to Iliac Crest Autograft for Posterolateral Lumbar Arthrodesis [DOI]
  35. 35 Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins [DOI]
  36. 36 Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites [DOI]
  37. 37 Controlled-release of rhBMP-2 carriers in the regeneration of osteonecrotic bone [DOI]
  38. 38 The bioactivity of rhBMP-2 immobilized poly(lactide-co-glycolide) scaffolds [DOI]
  39. 39 Synthesis and Characterization of Poly(lactic-co-glycolic) Acid Nanoparticles-Loaded Chitosan/Bioactive Glass Scaffolds as a Localized Delivery System in the Bone Defects [DOI]
  40. 40 The pore size of PLGA bone implants determines the de novo formation of bone tissue in tibial head defects in rats [DOI]
  41. 41 Sinus augmentation using BMP ‐2 in a bovine hydroxyapatite/collagen carrier in dogs [DOI]
  42. 42 Osteogenic effect of local, long versus short term BMP-2 delivery from a novel SPU–PLGA–βTCP concentric system in a critical size defect in rats [DOI]
  43. 43 In vitro and in vivo evaluation of bone formation using solid freeform fabrication-based bone morphogenic protein-2 releasing PCL/PLGA scaffolds [DOI]
  44. 44 Observations on the effect of BMP-2 on rat bone marrow cells cultured on titanium substrates of different roughness [DOI]
  45. 45 Histological investigation of osteoinductive properties of rh-BMP2 in a rat calvarial bone defect model [DOI]
  46. 46 In vitroandin vivoenhancement of osteogenic capacity in a synthetic BMP-2 derived peptide-coated mineralized collagen composite [DOI]
  47. 47 Cbfa1/Runx2‐deficiency delays bone wound healing and locally delivered Cbfa1/Runx2 promotes bone repair in animal models [DOI]
  48. 48 Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing [DOI]
  49. 49 In vitro cellular responses to bioerodible particles loaded with recombinant human bone morphogenetic protein-2 [DOI]
  50. 50 30. Two year follow up on patients in a pilot safety and efficacy study of OP-1 (rhBMP-7) in posterolateral lumbar fusion as a replacement for iliac crest autograft [DOI]
  51. 51 THE ROLE OF GROWTH FACTORS IN THE REPAIR OF BONE [DOI]
  52. 52 Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) [DOI]
  53. 53 Synthetic Biodegradable Polymers for Medical Applications [DOI]
  54. 54 Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites [DOI]
  55. 55 Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo
  56. 56 Sinus augmentation using BMP-2 in a bovine hydroxyapatite collagen carrier in dogs

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

4

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.